Skip to main content

FDA issues warning letters to 2 CBD brands marketing violations

Honest Globe and Biolyte Labs received letters for their marketing practices, as well as for substandard manufacturing practices, according to the Food and Drug Administration.
salazar

The Food and Drug Administration has sent warning letters to two companies for selling products with CBD in ways that violate the federal Food, Drug and Cosmetic Act. Honest Globe and Biolyte Labs received letters because CBD cannot be legally marketed as an inactive ingredient in OTC drug products that haven’t been reviewed and approved by the FDA, as well as substandard manufacturing practices. 

"The FDA continues to alert the public to potential safety and efficacy concerns with unapproved CBD products sold online and in stores across the country," said FDA principal deputy commissioner Dr. Amy Abernethy. "It's important that consumers understand that the FDA has only approved one drug containing CBD as an ingredient. These other, unapproved, CBD products may have dangerous health impacts and side effects. We remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD's safety. Meanwhile, we will continue to monitor and take action, as needed, against companies that unlawfully market their products — prioritizing those that pose a risk to public health."  

The FDA noted that the products covered by the warning letters had not gone through the FDA’s drug approval process and are considered unapproved new drugs. The agency also has not evaluated whether the products are effective for uses that manufacturers claim, what an appropriate dose might be, how they might interact with FDA-approved drugs or any potential side effects or safety concerns. 

The agency requested written responses from the companies within 15 working days, addressing how they will address the violations or providing reasoning and supporting information as to why they believe the products don’t violate the law. 
 

Most Popular Content

Albertsons' Roche: In-Store Unlocks New Opportunities to Rethink Retail Media Measurement

As in-store retail media surges with opportunities, Albertsons Media Collective's Liz Roche sees the retailer's stores as underleveraged canvases for inspiration and experimentation that extend beyond digital screens.
Albertsons

Inside Alcohol Delivery: Distilling Insights That Matter

October 30, 2025 Webinar: Get the insights you need to unlock growth in alcohol delivery. Register today.
Inside_Alcohol_Delivery_Distilling_Insights_That_Matter

Why Lidl Keeps Its Distance From Retail Media, AI Pricing as Others Double Down

While some (many) retailers are heading full speed into retail media, Lidl US isn't one of them. In fact, if you ask CEO Joel Rampoldt, it will never be one of them.
Lidl

Gen Z Rekindles In-Store Shopping Enthusiasm as Holiday Travel Rises

Consumers plan to travel, fuel up and shop in person more — signaling new engagement moments for marketers during the 2025 holiday season.
consumer gstv holiday 2025

Pacvue Preps Role in OpenAI’s Emerging Retail Ecosystem

How consumers discover products has fundamentally shifted, and Pacvue is planting its flag as a key player in social and conversational commerce to meet them there.
OpenAI
X
This ad will auto-close in 10 seconds